PepGen Inc. Common Stock
PEPG •
Sell Open
Signal type
Sell
Status
Open
Open Price
$4.89
Stop Loss
$6.15
Performance
65.44%
Days Open
29
Signal Setup
Signal Type Sell
Status Open
Open Date Mar 17, 2026
Open Price $4.89
Stop Loss $6.15
Timespan Day
Company Profile
Name PepGen Inc. Common Stock
Ticker PEPG
Market Cap $35.67M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $1.69
List Date May 6, 2022
Description
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
Website Open Company Website